Type 1 diabetes screening, identifying subtypes among key areas of scientific statement
SAN FRANCISCO — Identifying type 1 diabetes before stage 1 and developing more tailored therapies through a better understanding of the disease’s heterogeneity are key areas of a new scientific statement from The Endocrine Society.The statement, which was published in the Journal of Clinical Endocrinology and Metabolism and discussed during a symposium at ENDO 2025, was developed to